Prathap Ramalingam

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

15

H-Index

1

About

Prathap Ramalingam is a clinical researcher whose work centers on advancing surgical approaches in gynecologic oncology, with a particular focus on cervical cancer management. His most notable contribution is the landmark "23 Concerv" prospective trial, which investigated the safety and efficacy of conservative surgery for low-risk, early-stage cervical cancer. This study, published in 2019, has garnered 15 citations and represents a critical step toward de-escalating treatment intensity while preserving fertility and quality of life for eligible patients. Ramalingam’s research challenges traditional radical surgical paradigms, offering evidence that less invasive interventions can achieve comparable oncologic outcomes in carefully selected populations. His work is instrumental in shaping modern, patient-centered guidelines for cervical cancer care, bridging the gap between aggressive treatment and survivorship priorities. By prioritizing rigorous trial design and real-world applicability, Ramalingam has established himself as a key voice in the movement toward personalized, risk-adapted surgery. His findings continue to influence clinical decision-making and inspire further investigation into conservative strategies for gynecologic malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
23 Concerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer
15 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago